Corticosteroid use and abuse by medical practitioners for arthritis and related disorders in Pakistan

British Journal of Rheumatology

Volumn 36, Issue 1, 1997, Pages 91-94

  Farooqi, A Z ^a   Nasir ud din, ^a   Aman, R ^a   Qamar, T ^a   Aziz, S ^a  

^a PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

Corticosteroids; Pakistan; Steroid prescription; Steroid side effects; Treatment of arthritis

Indexed keywords

CORTICOSTEROID;

ARTHRITIS; ARTICLE; CATARACT; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DIABETES MELLITUS; DRUG ABUSE; HUMAN; HYPERTENSION; INTRAARTICULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MYOPATHY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PAKISTAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SKIN ATROPHY;

EID: 0030791404     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.1.91     Document Type: Article

References (16)

1. Hench PS, Kendall EC, Slocumb CH, Polley HF. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med 1950;85:545-666.
2. Hench PS. The reversibility of certain rheumatic and non-rheumatic conditions by the use of cortisone or of the pituitary adrenocorticotrophic hormone. Ann Intern Med 1952;36:1-38.
3. Bollet AJ, Black R, Bunim JJ. Major undesirable side-effects resulting from prednisolone and prednisone. J Am Med Assoc 1955;158:459-63.
4. Curtess PH, Clark WS, Hendon CH. Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy. J Am Med Assoc 1954;156: 467-79.
5. Carson DW. Drug treatment of rheumatoid arthritis. In: Scott JT, ed. Copeman's textbook of the rheumatic diseases, 5th edn. Edinburgh: Churchill Livingstone, 1978:404-6.
6. Byron MA, Mowatt AG. Corticosteroid prescribing in rheumatoid arthritis - the fiction and the fact. Br J Rheumatol 1985;24:164-6.
7. Friesen WT, Hekster YA, van de Putte LBA, Gribnau FWJ. Cross-sectional study of rheumatoid arthritis treatment in a university hospital. Ann Rheum Dis 1985;44:372-8.
8. Saag KG, Koehnke RN, Caldwell JR et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994;96:115-23.
9. Caldwell JR, Furst DE. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 1991;21:1-11.
10. Darmawan J, Wigley RD, Valkenburg HA, Muirden KD. Disturbing findings in Indonesia. Seapal Bull 1984;2:6-7.
11. Forster PJG, Grindulis KA, Neumann V, Hubbell S, McConkey B. High dose intravenous methyl-prednisolone in rheumatoid arthritis. Ann Rheum Dis 1982;41:444-6.
12. Neumann V, Hopkins R, Dixon J, Watkins A, Bird H, Wright V. Combination therapy with pulsed methyl-prednisolone in rheumatoid arthritis. Ann Rheum Dis 1985;44:747-51.
13. Corkill MM, Kirkham BW, Chikanza IC, Gibson T, Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized control trial. Br J Rheumatol 1990;29:274-9.
14. Cooper C, Kirwan JR. The risks of local and systemic corticosteroid administration. Baillière's Clin Rheumatol 1990;4:305-32.
15. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
16. Gibson T. A letter from Karachi. Br J Rheumatol 1993;32:625-7.